Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0CBDJ | ISIN: KYG8167W1380 | Ticker-Symbol: SMZ1
Tradegate
03.12.24
16:21 Uhr
0,404 Euro
-0,004
-0,86 %
Branche
Biotechnologie
Aktienmarkt
HANG SENG
1-Jahres-Chart
SINO BIOPHARMACEUTICAL LTD Chart 1 Jahr
5-Tage-Chart
SINO BIOPHARMACEUTICAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,4040,41617:47
0,4040,41617:48

Aktuelle News zur SINO BIOPHARM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SINO BIOPHARM Aktie jetzt für 0€ handeln
MiSINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF BENMELSTOBART INJECTION IN COMBINATION WITH ANLOTINIB HYDROCHLORIDE CAPSULE ...11
21.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW INDICATION APPLICATION FOR MARKETING OF ANLOTINIB HYDROCHLORIDE CAPSULE IN COMBINATION ...4
20.11.Sino Biopharmaceutical rises most in nearly 5 weeks on LaNova deal8
20.11.SINO BIOPHARM Spends RMB142M to Buy Shr in LaNova Medicines4
19.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - SIGNING EQUITY INVESTMENT AND STRATEGIC COOPERATION AGREEMENT WITH LANOVA MEDICINES4
14.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - APPROVAL GRANTED FOR CLINICAL TRIALS OF THE FOURTH-GENERATION EGFR INHIBITOR "TQB3002" IN THE UNITED STATES4
04.11.Leichter Wertverlust bei der Sino Biopharmaceutical-Aktie (0,4112 €)193Der Anteilsschein von Sino Biopharmaceutical notiert am Montag leichter. Das Papier notiert zur Stunde bei 0,41 Euro. Die Sino Biopharmaceutical-Aktie verzeichnet derzeit ein Minus von 4,39 Prozent....
► Artikel lesen
30.10.SINO BIOPHARM (01177): VOLUNTARY DISCLOSURE - 2024 THIRD QUARTER UPDATE9
30.10.SINO BIOPHARM (01177): CONNECTED TRANSACTION IN RELATION TO (1) ACQUISITION OF 29.99% EQUITY INTEREST IN THE TARGET COMPANY; AND (2) POSSIBLE VOLUNTARY ...7
21.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME5
21.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW INDICATION APPLICATION FOR MARKETING OF ANLOTINIB HYDROCHLORIDE CAPSULES IN COMBINATION ...3
09.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME3
08.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - SIGNING OF AN EXCLUSIVE LICENSE AND COOPERATION AGREEMENT WITH YZY BIOPHARMA7
04.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PROGRESS UPDATE ON THE "IMPLEMENTATION OF SHARE INCENTIVE SCHEME BY CHIA TAI TIANQING"4
03.10.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME5
27.09.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PHASE III STUDY RESULTS OF CULMERCICLIB IN COMBINATION WITH FULVESTRANT FOR TREATMENT OF HR+/HER2- ADVANCED ...7
26.09.SINO BIOPHARM (01177): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS5
26.09.SINO BIOPHARM (01177): NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED HOLDERS3
26.09.SINO BIOPHARM (01177): 2024 INTERIM REPORT1
25.09.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF "RIVASTIGMINE TRANSDERMAL PATCH"6
Seite:  Weiter >>
74 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1